|
Volumn 172, Issue 2, 2014, Pages 469-470
|
Outcomes with short-term versus long-term antiplatelet dual therapy after drug-eluting stenting: Quantifying the equivalence margins
|
Author keywords
Antiplatelet; Dual therapy; Equivalence; Meta analysis; Stenting
|
Indexed keywords
ANTICOAGULANT THERAPY;
ANTIPLATELET DUAL THERAPY;
ATTRIBUTABLE RISK;
CLINICAL EFFECTIVENESS;
COMPARATIVE STUDY;
DRUG ELUTING STENT;
DRUG SAFETY;
DRUG USE;
HUMAN;
LETTER;
LONG TERM CARE;
META ANALYSIS (TOPIC);
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
PUBLICATION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RISK FACTOR;
SHORT COURSE THERAPY;
THERAPEUTIC EQUIVALENCE;
TREATMENT DURATION;
CORONARY ARTERY DISEASE;
DRUG ADMINISTRATION;
META ANALYSIS;
TREATMENT OUTCOME;
ANTITHROMBOCYTIC AGENT;
CORONARY ARTERY DISEASE;
DRUG ADMINISTRATION SCHEDULE;
DRUG-ELUTING STENTS;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
TREATMENT OUTCOME;
|
EID: 84900107208
PISSN: 01675273
EISSN: 18741754
Source Type: Journal
DOI: 10.1016/j.ijcard.2013.12.228 Document Type: Article |
Times cited : (7)
|
References (7)
|